Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018


Posted on: 01 Aug 18

GAITHERSBURG, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, August 8, 2018.

Conference call details are as follows:

Date: August 8, 2018
Time: 4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:(877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:5886748
Webcast: www.novavax.com, “Investors”/ “Events”
 
Conference call and webcast replay:
  
Dates:Starting at 7:30 p.m. ET, August 8, 2018 until 7:30 p.m. ET August 15, 2018
Dial-in number:(855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:   5886748
Webcast:   www.novavax.com, “Investors”/ “Events”, until November 8, 2018

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases. It’s RSV and influenza nanoparticle vaccine candidates are Novavax’ most advanced clinical programs and are at the forefront of Novavax’ efforts to improve global health. For more information, please visit www.novavax.com.

Contact:        

Investors
Erika Trahan
Senior Manager, Investor & Public Relations
ir@novavax.com
240-268-2000

Westwicke Partners
John Woolford
john.woolford@westwicke.com 
443-213-0506

Media
Sam Brown
Mike Beyer 
mikebeyer@sambrown.com 
312-961-2502

GlobeNewswire
globenewswire.com

Last updated on: 02/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.